Table 2 Performance of IGT across all groups
| Â | Group | Group comparisons | Â | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HC* (N = 98) | DNS* (N = 61) | DSA* (N = 52) | HC* vs DNS* vs DSA* | DNS* + DSA* vs HC* | |||||||
Mean(SD) | Mean(SD) | Mean(SD) | F | d.f | p-value | HC* vs DNS* | HC* vs DSA* | DNS* vs DSA* | t | p-value | |
p-value | p-value | p-value | |||||||||
IGT* performance | |||||||||||
 Block1(Trials 1–20) | -5.27 (6.725) | -3.8 (7.269) | -3 (6.669) | 2.056 | 2 | 0.131 | 0.195 | 0.056 | 0.54 | 1.935 | 0.054 |
 Block2(Trials 21–40) | -4.08 (7.896) | -2.47 (8.848) | -1.54 (7.868) | 1.818 | 2 | 0.165 | 0.229 | 0.071 | 0.549 | 1.813 | 0.071 |
 Block3(Trials 41–60) | -1.55 (9.079) | -4.07 (9.072) | -2.38 (7.118) | 1.583 | 2 | 0.208 | 0.077 | 0.574 | 0.305 | -1.452 | 0.148 |
 Block4(Trials 61–80) | -0.51 (9.465) | -3.67 (8.471) | -3.94 (7.092) | 3.782 | 2 | 0.024 | 0.027 | 0.022 | 0.867 | -2.751 | 0.006 |
 Block5(Trials 81–100) | 1.33 (9.877) | -2.34 (9.345) | -2.85 (9.712) | 4.261 | 2 | 0.015 | 0.023 | 0.013 | 0.783 | -2.913 | 0.004 |
 Net total score | -10.06 (34.148) | -16.53 (33.422) | -13.73 (28.883) | 0.755 | 2 | 0.471 | 0.229 | 0.514 | 0.652 | -1.145 | 0.254 |
 PartA(Trails 1–40) | -9.35 (12.315) | -6.27 (13.956) | -4.54 (12.221) | 2.666 | 2 | 0.072 | 0.143 | 0.029 | 0.476 | 2.199 | 0.029 |
 PartB(Trails 41–100) | -0.735 (25.015) | -10.03 (20.881) | -9.17 (19.571) | 3.838 | 2 | 0.023 | 0.018 | 0.031 | 0.916 | -2.775 | 0.006 |